ADM is a shareholder in the Beyond BMI clinic, which provides clinical obesity care
The analysis found that: At 12 months, Omada members largely maintained their weight at GLP-1 discontinuation, with an average 0.8% weight change At 12 months, 63.2% of members maintained or continued to lose weight At 6 and 9 months, Omada members demonstrated 0.03% and 0.6% average weight change, respectively These findings suggest that Omada can play an integral role in supporting members during important transitions in their GLP-1 journey, including helping members maintain their weight well after GLP-1 discontinuation.
CDI teams should focus on ensuring narrative encounter notes explicitly support each diagnosis code
People take this brand as prescribed by the doctor for long-term nerve issues and weakness
These reactions typically include redness, swelling, and mild pain at the injection site
Its imperative that you reach out to your provider if you feel like you are having side effects that werent discussed
